DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Olfactory transduction	R-HSA-9751605	map04740	citiolone	14520	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	citiolone	14520	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	citiolone	14520	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	citiolone	14520	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	citiolone	14520	drug-path
Allograft rejection	R-HSA-9679028	map05330	citiolone	14520	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	citiolone	14520	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	benfotiamine	5282168	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	benfotiamine	5282168	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	benfotiamine	5282168	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	benfotiamine	5282168	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	benfotiamine	5282168	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	benfotiamine	5282168	drug-path
Axon guidance	R-HSA-422475	map04360	benfotiamine	5282168	drug-path
Asthma	R-HSA-444620	map05310	benfotiamine	5282168	drug-path
Allograft rejection	R-HSA-9679028	map05330	benfotiamine	5282168	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	benfotiamine	5282168	drug-path
Alzheimer's disease	R-HSA-1643685	0	benfotiamine	5282168	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	benfotiamine	5282168	drug-path
Huntington's disease	R-HSA-1643685	0	benfotiamine	5282168	drug-path